Merck’s Zostavax draws new litigation from patients alleging contract Shingles 7/21/17 FiercePharma

GG

Well-Known Member
Even as Merck & Co. confronts the prospect of a tough market competitor in GlaxoSmithKline’s Shingrix, the drugmaker’s shingles vaccine Zostavax faces a growing challenge in court.

Eighteen patients have filed a liability lawsuit against Merck, alleging the company produced and sold an “unreasonably dangerous vaccine” that caused serious injuries after vaccination. Hailing from a range of states including Louisiana, South Carolina, Tennessee, Michigan and Wisconsin, the plaintiffs filed their suit in Merck’s home state of New Jersey.

cont'd

http://www.fiercepharma.com/legal/more-patients-allege-they-suffered-injuries-from-merck-s-zostavax?utm_medium=nl&utm_source=internal&mrkid=4612423&mkt_tok=eyJpIjoiTkRrMU1XSXpaRGcxWm1NNCIsInQiOiJcL1d1Vlp5TWFwMGV0VkRqeXBpTkpvbkZvMCt4SGN6ODdHdTM2QWsxblZcL3g0N1RcL0EwenFtZXlhSE9oRXl5UnVpZjBjaGhNNWwrM3FMR25jUWhNbGI0d0Z2MHl3N1dhMUljbHhGdCttRkdFcm9FZ1B5VVJNeit6TU5pVFluNmpoVyJ9
 

Get Our Free ME/CFS and FM Blog!



Forum Tips

Support Our Work

DO IT MONTHLY

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Shopping on Amazon.com For HR

Latest Resources

Top